In our study, EGFR mutation was detected in 6% (3/50) of the patients with cancer and all of the EGFR-mutated patients had a histopathological diagnosis of adenocarcinoma and multiple HPV infection with HPV types 16 and 51. The gene discussed is EGFR; the disease is cancer.